China Universal Asset Management Co., Ltd. Beam Therapeutics Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.03 Billion
- Q4 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 17,794 shares of BEAM stock, worth $455,348. This represents 0.04% of its overall portfolio holdings.
Number of Shares
17,794
Previous 16,087
10.61%
Holding current value
$455,348
Previous $394,000
11.93%
% of portfolio
0.04%
Previous 0.04%
Shares
15 transactions
Others Institutions Holding BEAM
# of Institutions
234Shares Held
75.6MCall Options Held
438KPut Options Held
232K-
Farallon Capital Management LLC San Francisco, CA8.21MShares$210 Million1.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.84MShares$201 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.63MShares$195 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl6.53MShares$167 Million1.52% of portfolio
-
Arch Venture Management, LLC Chicago, IL4.83MShares$124 Million71.21% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $1.8B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...